MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

    MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)

    Objective: We investigated characteristics of clinical and cerebral glucose metabolic abnormalities in Parkinson’s disease (PD) with atrophy in the nucleus basalis of Meynert (NBM). Background:…
  • 2019 International Congress

    Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

    W. Kamel, J. Al Hashel (Beni Suef, Egypt)

    Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…
  • 2019 International Congress

    Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort

    F. Marxreiter, A. Cosma-Grigorov, H. Gassner, H. Meixner, Z. Kohl, M. Neurath, S. Wirtz, J. Winkler (Erlangen, Germany)

    Objective: Our goal was to evaluate, whether gut microbiota are altered in a Southern German PD cohort. In addition, we assessed changes in the microbiome…
  • 2019 International Congress

    Decline in Neural Connectivity in Olfactory Spatial Attention: A Comparative Study in the Progression of Parkinson’s Disease

    H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

    Objective: To study any inconsistency in the neural connections responsible for facilitating spatial recognition of olfactory stimuli as observed in people diagnosed with Parkinson’s Disease…
  • 2019 International Congress

    Impaired cerebral vasoreactivity in patients with Parkinson’s disease: clinical and imaging correlates

    I. Estrada-Bellmann, D. Cantú-García, S. Castillo-Torres, A. Mendoza-García, H. Sánchez-Terán, D. Díaz-Pérez, D. Roque-Martínez, S. Saldívar-Dávila, H. Martínez, T. Moreno-Andrade, B. Chávez-Luévanos, F. Góngora-Rivera (Monterrey, NL, Mexico)

    Objective: To determine the clinical and imaging correlates of impaired cerebral autoregulation as measured with cerebral vasoreactivity (CVR) in patients with idiopathic Parkinson’s disease (PD).…
  • 2019 International Congress

    “Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study

    J. Horsager, K. Knudsen, K. Andersen, C. Skjærbæk, T. Fedorova, J. Geday, J. Kraft, E. Bech, E. Danielsen, M. Møller, N. Pavese, D. Brooks, P. Borghammer (Aarhus N, Denmark)

    Objective: In a multi-modality imaging study, we test the hypothesis that Parkinson’s disease (PD) can be divided into two strikingly distinct phenotypes: (1) PD patients,…
  • 2019 International Congress

    Characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease patients

    K. Li, W. Su, H. Zhao, C. Li, X. Ma, B. Lou, M. Chen, H. Chen (Beijing, China)

    Objective: To explore the characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease (PD) patients Background: It is well-know that PD patients often…
  • 2019 International Congress

    Automated Interpretation of FP-CIT-SPECT images based on Artificial Intelligence

    M. Meier, J. Hammes, A. Drzezga, T. Dratsch, C. Kobe, D. Dos Santos, T. van Eimeren (Cologne, Germany)

    Objective: Our objective is to develop an AI-based approach to automatically rate FIP-CIT-SPECT data. Background: FP-CIT-SPECT visualizes the integrity of nigro-striatal dopaminergic synapses in vivo.…
  • 2019 International Congress

    Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

    G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to compare loss of PDE10A and DAT expression in patients with Parkinson’s disease. Background: Recent work has shown loss of PDE10A expression…
  • 2019 International Congress

    Micro structural Changes in Substantia Nigra are associated with Severity of Parkinson’s Disease.

    A. Safai, S. Rane, S. Prasad, J. Saini, P. Pal, M. Ingalhalikar (Pune, India)

    Objective: The aim of this study was to apply diffusion tensor imaging (DTI) to evaluate atrophy of the Substantia Nigra pars compacta (SNc), the pathological…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley